Primarni razsoj adenokarcinoma gastroezofagealnega prehoda v možgane

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:	Primarni razsoj adenokarcinoma gastroezofagealnega prehoda v možgane
Avtorji:	Mesti, Tanja (Avtor) Boc, Marko (Avtor) Reberšek, Martina (Avtor)
Jezik:	Slovenski jezik
Tipologija:	1.09 - Objavljeni strokovni prispevek na konferenci
Organizacija:	OI - Onkološki inštitut Ljubljana
Ključne besede:	rak požiralnika, rak želodca, radiokemoterapija, rak prebavil
Leto izida:	2014
UDK:	616.3-006
ISSN pri članku:	1408-1741
OceCobissID:	1807227
URN:	URN:NBN:SI:doc-AHJVPKX9
COBISS_ID:	1810043
Število ogledov:	1277
Število prenosov:	290
Datoteke:	PDF - Predstavitvena datoteka, prenos (445,19 KB)

Nadgradivo:	Šola: tumorji prebavil II, Ljubljana, 15. 11. 2013 Onkološki inštitut

Metapodatki:
Avtorske pravice:	by Authors
:

Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Licenca:	CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna

Povezava:	http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:	To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:	31.08.2018

Jezik:	Angleški jezik
Naslov:	[Primary spread of adenocarcinoma of gastroesophageal junction to the brain]
Povzetek:	In the last years, we have noted a decline in the incidence of gastric adenocarcinoma but at the same time also an increase in the incidence of adenocarcinoma of gastroesophageal (GE) junction (1). According to the 2012 Cancer Registry of Slovenia data, a total of 55 patients were diagnosed with gastric cancer in 2009, of which 363 were men and 192 were women (2). Generally, gastric cancer patients have a poor prognosis, especially in the case of primarily metastatic disease. Gastric cancer most commonly spreads to peritoneum, which is followed by lymph nodes, bones, lungs and liver (3-5). Metastases in the central nervous system mostly represent a late or rare manifestation (< 4%) (6). In the article, we present a patient with adenocarcinoma of GE junction with primary spread of the disease to the brain, who was treated with two lines of systemic therapy.

niGradiv

Nazaj